Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Sulfadoxine is a long acting sulfonamide used for the treatment or prevention of malaria. A medication used to prevent or treat malaria.
- Mechanism
- Curator reviewed
Sulfadoxine is a sulfa drug, often used in combination with pyrimethamine to treat malaria. This medicine may also be used to prevent malaria in people who are living in, or will be traveling to, an area where there is a chance of getting malaria. Sulfadoxine targets Plasmodium dihydropteroate synthase and dihydrofolate reductase. Sulfa drugs or Sulfonamides are antimetabolites. They compete with para-aminobenzoic acid (PABA) for incorporation into folic acid. The action of sulfonamides exploits the difference between mammal cells and other kinds of cells in their folic acid metabolism. All cells require folic acid for growth. Folic acid (as a vitamin) diffuses or is transported into human cells. However, folic acid cannot cross bacterial (and certain protozoan) cell walls by diffusion or active transport. For this reason bacteria must synthesize folic acid from p-aminobenzoic acid.
- Primary indication
- Sulfadoxine is used in combination with pyrimethamine for the treatment or prevention of malaria.Curator reviewed · 3 structured indications
- Formula / weight
- C12H14N4O4S · 310.329 g/mol (avg)
- First approval
- Canada, 1989 · United States, 1981
- Also known as
- Sulforthomidine · Sulphadoxine · Sulphormethoxine
- Code names
- J21.373J · RO 4-4393 · WR-4073
Resolves to
PJSFRIWCGOHTNF-UHFFFAOYSA-NSMILESCOC1=NC=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1OCWhat you can answer from here — as of September 12, 2026
Which drugs share a target with Sulfadoxine, and which of those have an active Phase 3 trial?